TNF and acute myeloid leukemia: One of the best-described molecular alterations that act as key contributors to AML pathogenesis is the overexpression of tumor necrosis factor (TNF), which promotes leukemic cell survival and proliferation and is thus associated with inflammation in AML and poor prognosis [4].